Related Experiment Videos

Minimum alveolar concentration of sevoflurane for tracheal extubation in children

H Higuchi1, T Ura, M Taoda

  • 1National Defense Medical College, Saitama, Japan.

Insights

The minimum alveolar concentration of sevoflurane to prevent coughing or movement during tracheal extubation in children is 2.3%. This finding helps reduce respiratory complications in pediatric anesthesia.

Area of Science:

  • Anesthesiology
  • Pediatric Medicine
  • Respiratory Care

Background:

  • Tracheal extubation during deep anesthesia reduces respiratory complications.
  • Sevoflurane is an effective anesthetic for pediatric procedures.
  • Determining optimal anesthetic concentrations is crucial for patient safety.

Purpose of the Study:

  • To determine the minimum alveolar concentration (MACextubation) of sevoflurane needed to prevent coughing or movement during tracheal extubation in children.
  • To establish a safe and effective sevoflurane dosage for pediatric extubation.

Main Methods:

  • A randomized study involving 30 nonpremedicated children (aged 2-10 years) undergoing plastic surgery.
  • Children were divided into five groups receiving different end-tidal sevoflurane concentrations (2.0% to 4.0%).
  • MACextubation was determined using logistic regression after discontinuing nitrous oxide and maintaining sevoflurane in oxygen.

Main Results:

  • The calculated MACextubation for sevoflurane was 2.3% (standard error 0.2%).
  • The 95% confidence limits for MACextubation were 1.2% and 2.7%.

Conclusions:

  • An end-tidal sevoflurane concentration of 2.3% allows for tracheal extubation without coughing or movement in 50% of anesthetized children aged 2-10 years.
  • This concentration can aid in minimizing respiratory complications during pediatric extubation.
Abstract

Related Concept Videos